Delay in coronary artery bypass grafting for STEMI patients improves hospital morbidity and mortality

Anthony Lemaire1, Tudor Vagaonescu2, Hirohisa Ikegami2

  • 1Division of Cardiothoracic Surgery, Department of Surgery, RUTGERS-Robert Wood Johnson Medical School, 125 Paterson Street, New Brunswick, New Jersey, 08903, USA. Anthony.lemaire@rwjms.rutgers.edu.

Insights

For ST-elevation myocardial infarction (STEMI) patients needing coronary artery bypass grafting (CABG), delaying surgery beyond 24 hours after admission is linked to better outcomes. This timing also reduces hospital length of stay and associated costs.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Health Services Research

Background:

  • Optimal timing for coronary artery bypass grafting (CABG) in ST-elevation myocardial infarction (STEMI) patients remains uncertain.
  • Urgent or emergent CABG is often performed within the first week of hospital admission for STEMI.
  • Understanding the impact of surgical timing on patient outcomes is crucial for clinical decision-making.

Purpose of the Study:

  • To evaluate and compare outcomes in STEMI patients undergoing CABG within different time intervals (within 24 hours, 2-3 days, 4-7 days) after non-elective admission.
  • To identify the optimal timing for CABG in STEMI patients to minimize complications and improve survival.
  • To assess the cost-effectiveness associated with different CABG timing strategies.

Main Methods:

  • Retrospective analysis of 5963 STEMI patients aged 30+ undergoing non-elective CABG within 7 days of admission (2010-2014 National Inpatient Sample).
  • Patients categorized into three cohorts: Group A (within 24h), Group B (2-3 days), Group C (4-7 days).
  • Comparison of postoperative complications, mortality, and length of stay (LOS) using Chi-square, logistic regression, and Wilcoxon rank sum tests.

Main Results:

  • Patients undergoing CABG within 24 hours (Group A) experienced higher rates of cardiac, respiratory, renal complications, and bleeding compared to Groups B and C.
  • In-hospital mortality was significantly higher in Group A (8.2%) versus Group B (3.5%) and Group C (2.9%).
  • Group A also had a significantly longer postoperative length of stay (median 7 days) compared to Groups B and C (median 6 days).

Conclusions:

  • Performing CABG within 24 hours of non-elective admission for STEMI is associated with increased hospital morbidity and mortality.
  • Delaying CABG beyond 24 hours may be beneficial for patient outcomes, including reduced complications and mortality.
  • Delayed CABG (beyond 24 hours) demonstrates cost-effectiveness through reduced hospital LOS and associated costs.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
161
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
564
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
143
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
173